METACAM - Meloxicam Injectable

• Works fast—first dose given in-clinic shows rapid and visible onset of pain relief and can be administered intravenously (IV) for best effect
• Only HALF the volume needed to treat dogs of the same body weight as RIMADYL® (carprofen) Injectable
• Can be administered with a small, 25-gauge needle
• Easy to draw up and inject, the smooth liquid is less viscous than RIMADYL Injectable

Carefully consider the potential benefits and risk of METACAM (meloxicam) Solution for Injection and other treatment options before deciding to use METACAM Solution for Injection. Use the lowest effective dose for the shortest duration consistent with individual response.

METACAM Solution for Injection should be administered initially as a single dose at 0.09 mg/lb (0.2 mg/kg) body weight intravenously (IV) or subcutaneously (SQ), followed, after 24 hours, by meloxicam oral suspension at the daily dose of 0.045 mg/lb (0.1 mg/kg) body weight.

Warning: Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats.

METACAM® (meloxicam) Solution for Injection is approved for use in dogs or cats (not indicated for osteoarthritis in cats)

Contraindications: Dogs with known hypersensitivity to meloxicam should not receive METACAM Solution for Injection.

Warnings: Not for use in humans. Keep this and all medications out of reach of children. Consult a physician in case of accidental ingestion by humans. 

For intravenous (IV) or subcutaneous (SQ) injectable use in dogs. All dogs should undergo a thorough history and physical examination before administering any NSAID. 

Dogs should be evaluated for pre-existing conditions and currently prescribed medications prior to treatment with METACAM Solution for Injection, then monitored regularly while on therapy. 

Precautions: The safe use of METACAM Solution for Injection in dogs younger than 6 months of age, dogs used for breeding, or in pregnant or lactating bitches has not been evaluated. 

Meloxicam is not recommended for use in dogs with bleeding disorders, as safety has not been established in dogs with these disorders. Safety has not been established for intramuscular (IM) administration in dogs.

As a class, cyclooxygenase inhibitory NSAIDs like METACAM Solution for Injection may be associated with gastrointestinal, kidney, or liver side effects. Concurrent use with another NSAID, corticosteroid, or nephrotoxic medication should be avoided or monitored closely.